A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)

Peking University First Hospital, Beijing

Peking University Third Hospital, Beijing

The First Bethune Hospital of Jilin University, Changchun

Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

Shanghai Skin Disease Hospital, Shanghai

Changshu No2 Peoples Hospital, Suzhou

Wuxi Peoples Hospital, Wuxi

Tianjin Medical University General Hospital, Tianjin

Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou

Dermatology Hospital of Jiangxi Province, Nanchang

The First Affiliated Hospital of Fujian Medical University, Fuzhou

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

The Second Xiangya Hospital of Central South University, Changsha

Yichang Central Peoples Hospital, Yichang

Nanyang First Peoples Hospital, Nanyang

Dermatology Hospital of Southern Medical University, Guangzhou

Chengdu Second Peoples Hospital, Chengdu

General Hospital of Ningxia Medical University, Yinchuan

Shandong Provincial Hospital For Skin Diseases,Shandong First Medical University, Jinan

Peoples Hospital of Xinjiang Uygur Autonomous Region, Ürümqi

The Second Hospital of Hebei Medical University, Shijiazhuang